{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:38:53Z","timestamp":1760240333372,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T00:00:00Z","timestamp":1524614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016304","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.avsg.2018.02.020","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T22:46:45Z","timestamp":1524005205000},"page":"37-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease"],"prefix":"10.1016","volume":"51","author":[{"given":"Peter","family":"Faries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3772-5887","authenticated-orcid":false,"given":"Michael","family":"Jaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"Khatib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Bosiers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reid","family":"Ravin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Rundback","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2018.02.020_bib1","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: Executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2018.02.020_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamasurg.2014.1007","article-title":"Fifteen-year trends in lower limb amputation, revascularization, and preventive measures among medicare patients","volume":"150","author":"Goodney","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/j.avsg.2018.02.020_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1161\/01.CIR.0000137913.26087.F0","article-title":"Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000","volume":"110","author":"Selvin","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2018.02.020_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00270-016-1504-1","article-title":"Endovascular therapy research in lower limb peripheral arterial disease published over a 5-year period: who is publishing and where?","volume":"40","author":"Asadi","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2018.02.020_bib5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/CIRCULATIONAHA.111.036574","article-title":"Percutaneous treatment of peripheral artery disease: novel techniques","volume":"126","author":"Schillinger","year":"2012","journal-title":"Circulation"},{"year":"2006","series-title":"Diagnosis and Management of Peripheral Arterial Disease: A National Clinical Guide","key":"10.1016\/j.avsg.2018.02.020_bib6"},{"key":"10.1016\/j.avsg.2018.02.020_bib7","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1161\/CIRCRESAHA.116.303503","article-title":"Endovascular intervention for peripheral artery disease","volume":"116","author":"Thukkani","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.avsg.2018.02.020_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2217\/ica.10.89","article-title":"Iliac artery revascularization: overview of current interventional therapies","volume":"2","author":"Lam","year":"2010","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.avsg.2018.02.020_bib9","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jvs.2007.07.027","article-title":"Primary iliac stenting versus transluminal angioplasty with selective stenting","volume":"46","author":"AbuRahma","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.02.020_bib10","first-page":"99","article-title":"Self-expanding stents and aortoiliac occlusive disease: a review of the literature","volume":"7","author":"Bekken","year":"2014","journal-title":"Med Devices (Auckl)"},{"key":"10.1016\/j.avsg.2018.02.020_bib11","first-page":"255","article-title":"The utility of superelasticity in medicine","volume":"6","author":"Duerig","year":"1996","journal-title":"Biomed Mater Eng"},{"key":"10.1016\/j.avsg.2018.02.020_bib12","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jcin.2017.05.015","article-title":"Self-expanding versus balloon-expandable stents for iliac artery occlusive disease: the randomized ICE trial","volume":"10","author":"Krankenberg","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.avsg.2018.02.020_bib13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/S0741-5214(98)70034-5","article-title":"Measurement of walking endurance and walking velocity with questionnaire: validation of the walking impairment questionnaire in men and women with peripheral arterial disease","volume":"28","author":"McDermott","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.02.020_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3400\/avd.tasc.15-01000","volume":"8","author":"Jaff","year":"2015","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.avsg.2018.02.020_bib15","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.CIR.92.3.614","article-title":"Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists","volume":"92","author":"Hiatt","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2018.02.020_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jvs.2008.12.073","article-title":"The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication","volume":"50","author":"Nicolai","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.02.020_bib17","first-page":"142","article-title":"Evaluation of walking impairment by questionnaire in patients with peripheral arterial disease","volume":"2","author":"Regensteiner","year":"1990","journal-title":"J Vasc Med Biol"},{"key":"10.1016\/j.avsg.2018.02.020_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1583\/13-4560.1","article-title":"The EPIC nitinol stent system in the treatment of iliac artery lesions: one-year results from the ORION clinical trial","volume":"21","author":"Clair","year":"2014","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2018.02.020_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jvir.2007.08.031","article-title":"Clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease","volume":"19","author":"Krol","year":"2008","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2018.02.020_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/01.RVI.0000140935.45313.35","article-title":"The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results","volume":"15","author":"Ponec","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.avsg.2018.02.020_bib21","unstructured":"Summary of Safety and Effectiveness for the Abbott Absolute Pro Vascular Self-Expanding Stent System. United\u00a0States: US Food and Drug Administration. Report No. P110028. Available at: http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110028b.pdf; 2012. Accessed May 25, 2018."},{"key":"10.1016\/j.avsg.2018.02.020_bib22","unstructured":"Summary of Safety and Effectiveness Data for the Bard E-Luminexx Vascular Stent. United States: US Food and\u00a0Drug Administration. Report No. P080007. Available at: http:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf8\/p080007b.pdf; 2008. Accessed May 25, 2018."},{"key":"10.1016\/j.avsg.2018.02.020_bib23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02733953","article-title":"Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial","volume":"15","author":"Palmaz","year":"1992","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.avsg.2018.02.020_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1583\/09-2917MR.1","article-title":"Express LD vascular stent in the treatment of iliac artery lesions: 24-month results from the MELODIE trial","volume":"17","author":"Stockx","year":"2010","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2018.02.020_bib25","unstructured":"Summary of Safety and Effectiveness for the Abbott Omnilink Elite Vascular Balloon-Expandable Stent System. United States: US Food and Drug Administration. Report P110043b. Available at: https:\/\/www.accessdata.fda.gov\/cdrh_docs\/pdf11\/P110043b.pdf. Accessed May 25, 2018."},{"key":"10.1016\/j.avsg.2018.02.020_bib26","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1583\/12-4010.1","article-title":"Sustained patency\u00a0and clinical improvement following treatment of atherosclerotic iliac artery disease using the Assurant cobalt iliac balloon-expandable stent system","volume":"20","author":"Molnar","year":"2013","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2018.02.020_bib27","unstructured":"Laird JR. Results from the iCARUS Study. Paper presented at: VIVA2012; Las Vegas, NV."},{"key":"10.1016\/j.avsg.2018.02.020_bib28","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1526602817720463","article-title":"Pivotal study of a Next-Generation balloon-expandable stent-graft for treatment of iliac occlusive disease","volume":"24","author":"Bismuth","year":"2017","journal-title":"J Endovasc Ther"},{"key":"10.1016\/j.avsg.2018.02.020_bib29","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jvs.2011.06.097","article-title":"A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease","volume":"54","author":"Mwipatayi","year":"2011","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2018.02.020_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1526602817692960","article-title":"Results from the VISIBILITY iliac study: primary and cohort outcomes at 9 Months","volume":"24","author":"Rundback","year":"2017","journal-title":"J Endovasc Ther"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509618302802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509618302802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:52:42Z","timestamp":1760187162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509618302802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"alternative-id":["S0890509618302802"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2018.02.020","relation":{},"ISSN":["0890-5096"],"issn-type":[{"type":"print","value":"0890-5096"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2018.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}